These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37117845)

  • 1. Refractory Pit1 plurihormonal tumours and thyrotroph adenomas.
    Nf L; Ai M
    Pituitary; 2023 Apr; 26(2):182-186. PubMed ID: 37117845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular, functional, and histopathological classification of the pituitary neuroendocrine neoplasms.
    Inomoto C; Tahara S; Oyama K; Kimura M; Matsuno A; Teramoto A; Osamura RY
    Brain Tumor Pathol; 2021 Jul; 38(3):183-188. PubMed ID: 34269950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma).
    Lenders N; McCormack A
    Pituitary; 2018 Apr; 21(2):217-229. PubMed ID: 29299820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary tumours - a large retrospective single-centre study of over 2300 cases. Experience of a tertiary reference centre.
    Rak B; Maksymowicz M; Grzywa TM; Sajjad E; Pękul M; Włodarski P; Zieliński G
    Endokrynol Pol; 2020; 71(2):116-125. PubMed ID: 32154573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plurihormonal Pituitary Neuroendocrine Tumours - A Single Centre Experience.
    Mihajlović M; Pekić S; Doknić M; Stojanović M; Rašić D; Miljić D; Petakov M; Manojlović Gačić E
    Int J Surg Pathol; 2024 May; 32(3):470-477. PubMed ID: 37438981
    [No Abstract]   [Full Text] [Related]  

  • 6. [New pathological classification and clinical implications of pituitary neuroendocrine tumors of the 2022 WHO version].
    Xie J; Wu ZB
    Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(47):3723-3726. PubMed ID: 36517420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular biology of thyrotroph pituitary neuroendocrine tumors.
    Horiguchi K
    Endocr J; 2023 Feb; 70(2):135-139. PubMed ID: 36653153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plurihormonal pituitary adenomas: immunostaining of all pituitary hormones is mandatory for correct classification.
    Ho DM; Hsu CY; Ting LT; Chiang H
    Histopathology; 2001 Sep; 39(3):310-9. PubMed ID: 11532042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plurihormonal Pit-1 lineage adenoma presenting as meningitis with recurrence after somatostatin analogue.
    Olmedilla Y; Khan S; Young V; Joseph R; Cudlip S; Ansgorge O; Grossman A; Pal A
    Endocrinol Diabetes Metab Case Rep; 2019 Mar; 2019():. PubMed ID: 30897548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of the 2022 WHO Classification of Pituitary Tumors.
    Asa SL; Mete O; Perry A; Osamura RY
    Endocr Pathol; 2022 Mar; 33(1):6-26. PubMed ID: 35291028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin receptor profile in pituitary thyrotroph adenomas.
    Thodou E; Kontogeorgos G
    Clin Neurol Neurosurg; 2020 Aug; 195():105865. PubMed ID: 32416325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silent somatotroph tumour revisited from a study of 80 patients with and without acromegaly and a review of the literature.
    Chinezu L; Vasiljevic A; Trouillas J; Lapoirie M; Jouanneau E; Raverot G
    Eur J Endocrinol; 2017 Feb; 176(2):195-201. PubMed ID: 27913611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plurihormonal PIT-1-Positive Pituitary Adenomas: A Systematic Review and Single-Center Series.
    Andrews JP; Joshi RS; Pereira MP; Oh T; Haddad AF; Pereira KM; Osorio RC; Donohue KC; Peeran Z; Sudhir S; Jain S; Beniwal A; Chopra AS; Sandhu NS; Tihan T; Blevins L; Aghi MK
    World Neurosurg; 2021 Jul; 151():e185-e191. PubMed ID: 33862299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell Adenomas.
    Lee JC; Pekmezci M; Lavezo JL; Vogel H; Katznelson L; Fraenkel M; Harsh G; Dulai M; Perry A; Tihan T
    Endocr Pathol; 2017 Dec; 28(4):287-292. PubMed ID: 28994039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.
    Batista RL; Trarbach EB; Marques MD; Cescato VA; da Silva GO; Herkenhoff CGB; Cunha-Neto MB; Musolino NR
    World Neurosurg; 2018 Dec; 120():e241-e246. PubMed ID: 30138730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDKN2A/p16 inactivation is related to pituitary adenoma type and size.
    Seemann N; Kuhn D; Wrocklage C; Keyvani K; Hackl W; Buchfelder M; Fahlbusch R; Paulus W
    J Pathol; 2001 Apr; 193(4):491-7. PubMed ID: 11276008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin receptor subtypes mRNA in TSH-secreting pituitary adenomas: a case showing a dramatic reduction in tumor size during short octreotide treatment.
    Horiguchi K; Yamada M; Umezawa R; Satoh T; Hashimoto K; Tosaka M; Yamada S; Mori M
    Endocr J; 2007 Jun; 54(3):371-8. PubMed ID: 17420609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observation of Clinicopathologic Features of Pituitary Adenoma With Neuronal Differentiation.
    Zheng L; Yan X; Hu C; Zhang P; Chen Y; Zheng Q; Hu L; Wang M; Li G; Wu P; Jiang C; Tian J; Zhang S; Wang X
    Front Endocrinol (Lausanne); 2022; 13():848762. PubMed ID: 35370935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of human Pit-1 product in the human pituitary and pituitary adenomas. Immunohistochemical studies using an antibody against synthetic human Pit-1 product.
    Sanno N; Teramoto A; Matsuno A; Osamura RY
    Arch Pathol Lab Med; 1996 Jan; 120(1):73-7. PubMed ID: 8554449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-L1 Is Preferentially Expressed in PIT-1 Positive Pituitary Neuroendocrine Tumours.
    Turchini J; Sioson L; Clarkson A; Sheen A; Gill AJ
    Endocr Pathol; 2021 Sep; 32(3):408-414. PubMed ID: 33694064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.